Novel and Rare Fusion Cancer Detection

​Join Beckman Coulter for a Lunch & Learn exploring new approaches to detecting novel and rare cancer gene fusions.

​Gene fusions can provide important insights into cancer biology and may serve as valuable biomarkers for research and clinical development. During this session, they will discuss how scalable and automatable nucleic acid extraction and library preparation workflows can support the detection of both known and previously unidentified fusion events.

​Learn how these technologies can help streamline sample preparation, improve workflow scalability, and support researchers working to identify rare genomic alterations.

​Speakers:

​Dr. Serena Dougherty
Beckman Coulter, Genomics Consultant

​Chelsea McCallister
Integrated DNA Technologies (IDT), Territory Sales Manager, NGS Clinical Solutions

​Join us for lunch, learn more about the workflow and applications, and bring your questions for the speakers!